Events

2018

February 11-15, 2018
July 19-20, 2018
November 7-12, 2018
October 2-5, 2018
August 27-31, 2018
May 1-3, 2018
November 13-16, 2018
November 1-4, 2018
October 19-23, 2018
June 1-5, 2018
April 14-18, 2018

2017

Neoantigen Summit
Presenting: John Simmons, PhD
Topic: NGS Solutions for Immuno-Oncology
November 14, 2017
10th Annual Dx Clinical Affairs & Regulatory Approvals
Presenting: Jennifer Dickey, Ph.D., RAC
Topic: Regulatory Clearance for Next Generation Sequencing IVDs. 11:15 AM
Presenting: Jennifer Dickey, Ph.D., RAC
Topic: Session 3: FDA Submission & Review Processes That Ensure IVD Clearance. 9:15 AM
November 6, 2017
2017 AMDM IVD Focus Meeting
Presenting: Joshua D. Levin, Ph.D., RAC
Topic: The Development of an IVD-Compliant Quality System in a CLIA QMS Background. 3:45 PM - 4:15 PM
October 5, 2017
AACR-NCI-EORTC
Presenting: Luis Diaz, MD. and Victor Velculescu, MD, Ph.D.
Topic: Plenary Session 1: Acquired Resistance to Checkpoint Inhibitors. Resistance to PD-1 Blockade in Melanoma. 4:30 PM - 6:30 PM
October 26 - 30, 2017
World CDx Boston
Presenting: John Simmons, PhD
Topic: NGS Solutions Across the Oncology Drug Development Continuum: From Biomarker Discovery to IVD. 3:00 PM
October 18, 2017
Immuno-Oncology Summit Boston
Presenting: John Simmons, PhD
Topic: NGS Solutions Across the Oncology Drug Development Continuum: From Biomarker Discovery to IVD
August 29, 2017
Next Generation Dx Summit
Presenting: John Simmons, PhD
Topic: SC14: Liquid Biopsy: Technology, Applications, Regulations and Reimbursement. 6:45-9:15 PM
August 16, 2017
World CDx Market Access & Precision Medicine
Presenting: Jennifer Dickey, PhD, RAC
Topic: The Diagnostic Perspective: Maximizing Global Access for Precision Medicine. 11:45 AM
Presenting: Jennifer Dickey, PhD, RAC
Topic: Keynote Panelist--How Can We Evolve the Definition of Value for Targeted Therapeutics to be Relevant to Payers, Providers, and Patients. 10:15 AM
July 19, 2017
Biomarkers & Immuno-Oncology World Congress 2017
Presenting: John Simmons, PhD
Topic: NGS Solutions Across IO Drug Development: From Biomarker Discovery to IVD. 8:25 AM
May 2 - 3, 2017
AACR Annual Meeting
Presenting:
Topic: Late-Breaking Poster Session #12: Clinical Research 2/ Endocrinology. Poster Title: LB-246- Detection of circulating tumor DNA in early stage cancers. Washington Convention Center. Halls A-C. Section 34. 1:00 – 5:00 PM
Presenting: Victor Velculescu, MD, PhD
Topic: Educational Session ED15: Integrating Genomic Analyses of Immunotherapy. Presentation Title: Dynamics of genomic and neoantigen landscape during immune checkpoint blockade. Washington Convention Center. Ballroom A-B. Level 3. 10:45 - 11:10 AM
Presenting: Victor Velculescu, MD, PhD
Topic: Recent Advances in Diagnostics and Therapeutics Research Session RADT12: Liquid Biopsies-The New Pathology. Presentation Title: Liquid biopsy analyses for detection and characterization of human cancer. Washington Convention Center. Ballroom C. Level 3. 2:00 - 2:25 PM
Presenting: Victor Velculescu, MD, PhD, Luis A. Diaz, MD, Nickolas Papadopoulos, PhD & Bert Vogelstein, MD
Topic: Awards and Lectures: AP03 - Eleventh Annual AACR Team Science Award. Washington Convention Center. Hall D-E.Level 2. 8:00 - 9:00 AM
Presenting:
Topic: Major-Symposium Session SY16: Mechanisms Regulating Immune Checkpoint Therapies. Presentation Title: NG01- Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer. Washington Convention Center. Room 146.Level 1. 11:25 - 11:45 AM
Presenting: Monica Nesselbush
Topic: Mini-Symposium Session MS.CL10.02: Liquid Biopsies 4. Presentation Title: #4954-Clinical validation of a cell-free DNA liquid biopsy approach for noninvasive molecular profiling. Washington Convention Center. Room 146, Level 1. 4:20 - 4:35 PM
Presenting: Marián Novak PhD
Topic: Poster Session #8: T-Cell Immunity to Cancer- New Process Poster Title: Accurate identification and prioritization of candidate neoantigens from integrated cancer exome and transcriptome sequencing of FFPE samples. Washington Convention Center. Halls A-C. Section 26. 1:00 - 5:00PM.
April 1 - 5, 2017
World CDx Europe
Presenting: John Simmons PhD
Topic: NGS Solutions Across the Oncology Drug Development Continuum: From Biomarker Discovery to IVD. 4:10 PM.
March 29, 2017
The Molecular Medicine Tri-Con
Presenting: John Simmons PhD
Topic: SC11: Liquid Biopsy Technologies and Applications. 5:30 - 8:30 PM
February 19, 2017

2016

SITC National Harbor, MD
Presenting: Maria Sevdali, PhD
Topic: A non-invasive approach to assess tumor mutation load for treatment with cancer immunotherapy: Abstract #291

2016

Neoantigen Summit
Presenting: John Simmons
Topic: 14.40 | Accurate Identification and Prioritization of Candidate Neoantigens from Cancer Exome Sequencing
Oct 18, 2016
World CDx Boston
Presenting: Theresa Zhang, PhD
Topic: 11.30 Circulating Tumor DNA: Applications and Challenges This talk will discuss novel applications of ctDNA analysis in clinical and pharmaceutical research settings and highlight the major challenges encountered Recent studies have demonstrated that ctDNA can be effective pharmacodynamics and early response markers for drug development
Oct 18, 2016
Immuno-Oncology Summit
Presenting: Johns Simmons, Ph.D
Topic: 10 AM: Approaches to Assess Tumor Mutation Load for Selecting Patients for Cancer Immunotherapy
Presenting: Luis A. Diaz, M.D.
Topic: 2:20 PM: PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Aug 29, 2016
Molecular Diagnostics Europe
Presenting: Luis Diaz, M.D.
Topic: Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord
April 7, 2016
Circulating Biomarkers World Congress
Presenting: Theresa Zhang, Ph.D; Sonya Parpart-Li, Ph.D.
Topic: Methods to Detect and Quantify Circulating Cell-Free DNA: Opportunities for Liquid Biopsy Development
March 21-22, 2016
World CDx London
Presenting: Theresa Zhang, Ph.D.
Topic: Aligning Drug-CDx Co-Development
March 15-16, 2016
Molecular Med Tri-Con
Presenting: Theresa Zhang, Ph.D.
Topic: Short Course 13: Liquid Biopsy Technologies Overview will take place on Sunday, March 6 at 5:30 pm.
Presenting: Victor Velculescu, M.D., Ph.D.
Topic: Characterization of Driver Alterations in Tissue and Liquid Biopsies
Presenting: Luis A. Diaz, M.D.
Topic: Novel Clinical Applications of Cancer Genomics
Presenting: Sonya Parpart-Li, Ph.D.
Topic: Short Course 25: The Detection and Characterization of Circulating Biomarkers will take place on Thursday, March 10 at 6:30 pm.
March 6-11, 2016
The Biomarker Conference
Presenting: Theresa Zhang, Ph.D.
Topic: Application of Circulating Cell Free Tumor DNA
February 18-19, 2016
Symposium on Anti-Angiogenesis and Immune Therapies for Cancer
Presenting: Dr. Luis A. Diaz, MD
Topic: Mutational load as predictor of response.
February 5, 2016
Immunotherapy World
Presenting: Theresa Zhang, Ph.D.
Topic: Standardization and harmonization in therapies/CDx adoption
January 25, 2016

2015

November 20-21, 2015
SelectBio, Boston, MA
Presenting: Theresa Zhang, PhD; Sonya Parpart-Li, PhD
Topic: Methods to detect and quantify ctDNA
November 16-17, 2015
CNAPS, Berlin
Presenting: Sonya Parpart-Li, PhD for Luis Diaz, MD.
Topic: Clinical Applications of Circulating Tumor DNA
September 10-12, 2015
September 8-11, 2015
Next Gen Dx, Washington DC
Presenting: Sonya Parpart-Li, PhD
Topic: Emerging Application and Clinical Impact of Liquid Biopsy Approaches in Cancer.
Aug. 18–20, 2015
Molecular Biomarkers for Precision Medicine in Oncology: Recent Advances and Future Perspectives, Seattle, WA
Presenting: Mark Sausen, Ph.D
Topic: Methodologies for biomarker testing in cancer
July 22-25, 2015
Molecular Therapeutics of Cancer Research Conference, Medford MA
Presenting: Mark Sausen, Ph.D
Topic: Comprehensive detection of sequence and structural alterations in the circulation of cancer patients
July 12-16, 2015
GTC, San Diego, CA
Presenting: Theresa Zhang, PhD
Topic: Liquid Biopsies to Identify Actionable Alterations in Circulation of Lung Cancer Patients
June 11-12, 2015